← All trials
NCT03651011
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 10, 2018
- Primary completion
- Aug 10, 2020
- Completion date
- Aug 10, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Southern DenmarkLead sponsor
- University of Southern DenmarkReponsible party - principal investigator
- University of CopenhagenCollaborator
- Queen's University, BelfastCollaborator
- AP Moeller FoundationCollaborator
- University of Southern DenmarkStudy chair
- University of CopenhagenStudy chair
- Queen's University, BelfastStudy chair
- University of Southern DenmarkOverall official - principal investigator
- University of Southern DenmarkStudy director
- Synoptik-FondenCollaborator
- Toyota-FondenCollaborator
- Yamagata UniversityCollaborator
- Yamagata UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.